< Back to companies
AlphaMol (阿尔法分子科技)

AlphaMol (阿尔法分子科技)

Shen Zhen Shi, China

AlphaMol is an AI-based bio-pharmaceutical company focusing on G protein-coupled receptor drug discovery. We aim at discovering and developing new drug molecules to treat major human disorders and diseases including those against infections, cancers, Alzheimer's disease, diabetes, aging and others. We primarily focus on G protein-coupled receptors (GPCRs) related signalling pathway.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2020
Website
alphamol.com
Only accessible to MedStartr community members. Join now

What do you think of AlphaMol (阿尔法分子科技)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now